Modeling The Epidemiological Impact Of Human Hookworm Infection by Skrip, Laura
Yale University
EliScholar – A Digital Platform for Scholarly Publishing at Yale
Public Health Theses School of Public Health
January 2013
Modeling The Epidemiological Impact Of Human
Hookworm Infection
Laura Skrip
Yale University, laura.skrip@yale.edu
Follow this and additional works at: http://elischolar.library.yale.edu/ysphtdl
This Open Access Thesis is brought to you for free and open access by the School of Public Health at EliScholar – A Digital Platform for Scholarly
Publishing at Yale. It has been accepted for inclusion in Public Health Theses by an authorized administrator of EliScholar – A Digital Platform for
Scholarly Publishing at Yale. For more information, please contact elischolar@yale.edu.
Recommended Citation
Skrip, Laura, "Modeling The Epidemiological Impact Of Human Hookworm Infection" (2013). Public Health Theses. 1272.
http://elischolar.library.yale.edu/ysphtdl/1272
	   i 
 
 
 
 
 
 
MODELING THE EPIDEMIOLOGICAL IMPACT OF HUMAN HOOKWORM 
INFECTION 
 
By Laura Skrip 
 
A Thesis Presented to 
 
The Faculty of the Department of Epidemiology and Public Health 
 
Yale University 
 
 
 
 
In Candidacy for the Degree of 
 
Master of Public Health 
 
 
2013 
 

	   iii 
ABSTRACT 
Background: Chronic hookworm infection affects an estimated 576 to 740 million people 
worldwide.  Despite mass drug administration efforts, the morbidity associated with this soil-
transmitted helminth remains a significant public health issue.  Due to inter- and intra- 
community heterogeneity in susceptibility to infection, mathematical modeling can serve as an 
effective and efficient tool for investigating hookworm transmission in different settings and for 
guiding policymakers to consider new treatment and prevention strategies.   
Methods: Here we developed an age-structured, compartmental S-I model to identify 
epidemiological parameters for hookworm infection and to assess rates of attributable anemia 
within the population of Zanzibar.  The model was first used to address the relative contributions 
of age group (adults versus children) and infection intensity status (high versus low) in 
transmission.  The Markov chain Monte Carlo (MCMC) method was implemented to generate 
negative binomial distribution parameters for describing population-level parasite aggregation. 
Gibbs sampling and data on prevalence of hookworm infection were used in a subsequent 
MCMC to parameterize the overall model and account for uncertainty.  Maximum likelihood 
point estimates for force of infection and natural recovery were derived from the 10,000 
posterior distributions generated.  Empirical data on average hemoglobin levels for given fecal 
egg count categories were included in the analysis to give distributions for the relative risk of 
moderate-to-severe anemia (hemoglobin < 90 g/L) among infected versus susceptible 
individuals.   
Results: Using maximum likelihood estimates for the negative binomial distribution parameters, 
it was determined that children prone to high intensity hookworm infections were 4.9 times as 
infectious as children prone to lower intensity infection; high intensity infection adults were 
	   iv 
considered to be 4.7 times as infectious as low intensity infection adults. Model predictions with 
and without uncertainty were consistent in estimating that approximately 10% of the infected 
child population experienced moderate-to-severe anemia attributable to hookworm infection.  
Conclusion: The present model provides a population-level compartmental model framework 
for assessing hookworm-attributable morbidity independent of assumptions about worm burden 
thresholds.  To evaluate the effectiveness of different intervention strategies at reducing the 
incidence of infection and rates of hookworm-attributable anemia, the current epidemiological 
model can be extended structurally to include treatment and vaccine parameters. 
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INTRODUCTION 
Background 
Affecting an estimated 576-740 million people worldwide, human hookworm infection 
contributes significantly to the global incidence of iron-deficiency anemia, protein malnutrition, 
and other comorbid conditions [1-3].  In fact, chronic hookworm infection accounts for nearly 
22.1 million of the 57 million DALYS associated with all neglected tropical diseases [1].  Most 
human infections are attributed to two hookworm species, Necator americanus and Ancylostoma 
duodenale, which are endemic in tropical and subtropical regions of sub-Saharan Africa, south 
China, Southeast Asia, and the Americas [4].  The climate in these regions is conducive to larval 
survival, and in less developed regions, poor nutritional status combined with lacking sanitation 
infrastructure provides for significant morbidity due to high transmission rates and chronic 
infection [5].  
Hookworm infection results as third-stage larvae (L3) penetrate exposed skin upon 
contact with contaminated soil.  The larvae enter the circulatory system and migrate to the lungs. 
After coughing expels them from the respiratory tract, the parasites are swallowed into the 
digestive system and form a buccal capsule equipped with cutting plates [6, 7].  Larvae 
ultimately mature into adult hookworms in the small intestine, where their feeding on the mucosa 
and submucosa leads to a daily loss of up to 9 ml of blood [8].  While in the intestine, adult 
hookworms reproduce and their eggs are excreted with fecal matter [9].  Low iron bioavailability 
in hookworm-endemic regions increases susceptibility to iron deficiency anemia due to diets 
heavily dependent on starch-based foods, such as cassava [10]. 
 
Current and Projected Control Measures 
Over the past several decades, widespread deworming efforts targeting high-risk  
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individuals have been undertaken to reduce the prevalence and intensity of STH infection [11].  
Such programs have involved the administration of single-doses of benzimidazoles, such as 
mebendazole (500 mg dose) and albendazole (400 mg dose), in schools and other community 
settings [12]. In 2001, the World Health Assembly established a goal of treating 75% of all at-
risk school-aged children with anthelminthics by 2010 [13]. However, it is projected that long-
term mass treatment using benzimidazoles will be increasingly less effective due to rapid rates of 
reinfection and the likely emergence of drug resistance [14-16].  In addition, individual- and 
community-level differences in benzimidazole efficacy have been demonstrated [11], with a 
recent meta-analysis of randomized placebo-controlled studies reporting cure rates for single-
dose oral albendazole (400 mg) as low as 40% in Kenya (n = 34) during 1999 to as high as 100% 
in Haiti (n = 12) during 1990 [17]. 
In response to limited treatment options and variable efficacy, efforts are currently 
underway to identify antigens for development of a human hookworm vaccine.  The current 
approach involves investigation into a bivalent vaccine that will affect both the larval and adult 
stages of the parasite’s life cycle [4]. One potential class of antigens includes the aspartic 
proteases (APRs), which are proteolytic enzymes that interfere with the parasite’s digestion of 
skin macromolecules and thus inhibit larval movement across the epithelial barrier and into the 
circulatory system [7, 8].  Another class, the Ancyclostoma secreted proteins (ASPs), are 
involved in maturation of L3 larvae to adult hookworms upon human serum stimulation [8].  
Table 1 outlines recently investigated vaccine targets and the current phase of development for 
each. 
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Study Target Population 
The island region of Zanzibar is located off the coast of Tanzania. In 1994, a school-
based deworming program was launched by the local Ministry of Health and Social Welfare and 
involved administration of single does of mebendazole two to three times per year on Pemba, the 
smaller of the two islands making up Zanzibar [18].  The program was eventually extended to all 
of Zanzibar with reported coverage rates as high as 90% of all primary school children [19].  The 
school-based program was disrupted in 2000 due to difficulties in securing sufficient 
anthelmintic drugs.  It was restarted in 2003 with the administration of albendazole and 
praziquantel [20].  In 2001, Zanzibar also launched a community-wide campaign, The Global 
Elimination of Lymphatic Filariasis (GELF), which involved annual administration of 
albendazole and ivermectin to all eligible adults and children.  The combined effect of GELF and 
school-based deworming programs on helminth infection has been investigated [21].  The safety 
of combining community-based programs to address STH and other endemic parasitic infections 
has been considered as well [22].  Despite decades of large-scale deworming programs, infection 
prevalence remains as high as 99% in regions of the islands and some degree of iron deficiency 
anemia has been found to afflict about 60% of children [18, 19].  Due to extensive evaluation of 
the impact of mass drug administration in Zanzibar, trends in hookworm prevalence and disease 
intensity have been well documented. The region would thus be a feasible and logical site for 
future effectiveness trials on vaccination and other intervention strategies.  
 
Existing Models 
Mathematical modeling offers an effective and efficient way of evaluating hookworm 
transmission dynamics and considering how new intervention strategies could impact rates of 
	   4 
morbidity.  Since the 1980’s, models on helminth infection have evolved to include new 
approaches to treatment, prevention, and control.  Anderson and May proposed an early worm-
based model for evaluating the basic reproductive rate (R0) for macroparasites and considering 
the impact of treatment in terms of changing the mean worm burden and reducing R0 to below 
unity [23].  Medley et al expanded upon this model to specifically investigate the effect of 
anthelminthic treatment on symptoms attributable to roundworm (Ascaris lumbridoides) 
infection [24]. The use of a worm burden threshold to model levels of morbidity was further 
extended by Chan and his colleagues who incorporated age structuring into the Anderson and 
May model and compared predictions when different mechanisms of population-level host 
mixing were considered [25].  Most recently, Sabatelli et al developed an individual-based model 
to consider the impact of human hookworm vaccination in the context of community-level 
parasite aggregation and variation in host susceptibility [5].   
Despite significant progress in the development of mathematical models for helminth 
infections over the last several decades, the Disease Reference Group on Helminth Infections 
(DRG4), established by the Special Programme for Research and Training in Tropical Diseases 
(TDR), recently issued an agenda highlighting research priorities and gaps to address when 
modeling helminth infections [26].  Notably, it was recommended that models should be refined 
to more accurately capture the relationship between morbidity and the evolving infection status 
of individuals in regions with intermittent treatment and control campaigns [26]. 
 
Study Objectives 
Here we construct and parameterize an age-structured, risk-stratified deterministic model 
to identify epidemiological parameters for hookworm infection and attributable morbidity within 
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the population of Zanzibar. For the present model, morbidity was defined as anemia with a 
hemoglobin level less than 90 g/L.  An expanded model representing treatment and vaccination 
is also presented but not parameterized.  As far as we know, this is the first population-based 
deterministic model for evaluating the epidemiological impact of human hookworm infection. 
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METHODS 
Description of Compartmental Model 
A deterministic model was constructed to evaluate the population-level transmission 
dynamics of human hookworm infection and estimate moderate-to-severe anemia among 
infected children in Zanzibar.  This age-structured model (Figure 1) includes child compartments 
(subscript C) representing individuals younger than 15 years old and adult compartments 
(subscript A) representing individuals 15 years and older.  The age cutoff was chosen since 
treatment programs in Zanzibar target school-age children and the model was developed for 
ultimate use in evaluating similarly targeted intervention strategies.  To reflect community-level 
overdispersion of hookworm burden, both age classes were subdivided with individuals prone to 
high intensity infection (subscript 20) distinguished from those prone to low intensity infection 
(subscript 80).  Individuals in the high intensity compartments are expected to be more 
susceptible to infection due to nutritional, behavioral, and genetic factors as well as past infection 
experiences [23, 27].  The negative binomial distribution is frequently used when modeling 
parasite aggregation, and within high aggregation communities, it is often found that 20% of a 
given population harbors over 80% of the burden [28] such that for the present model, both age 
classes were risk-stratified to distinguish between those prone to heavy (20% of population) 
versus light (80% of population) intensity infections.  The overall S-I model structure assumed 
underlying levels of anemia due to nutritional and other factors.  Moderate-to-severe anemia was 
defined in terms of hemoglobin levels less than 90 g/L.  This cut off is consistent with that 
previously used during trials to investigate the effectiveness of hookworm control measures in 
Zanzibar [10].  Children and adults transition from the S compartments to I compartments at a 
rate defined by the force of infection γ, given by the following equation:   
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! = !!!"× !!!"! + !!!"× !!!"! + !!!"× !!!"! + !!!"× !!!"!    (1) 
All infected individuals are assumed to acquire hookworms through contact with 
contaminated soil and have a chance of natural recovery back to the S compartment at a rate, ρ.  
The movement of individuals between compartments is given by eight (8) ordinary differential 
equations. 
!!!!"!" = !!"! − !!!!!" − !!!!" − !!!!" + !!!!"        (2) 
 !!!!"!" = !!"! − !!!!!" − !!!!" − !!!!" + !!!!"        (3) 
 !!!!"!" = !!!!" − !!!!!" − !!!!" − !!!!"          (4) 
 !!!!"!" = !!!!" − !!!!!" − !!!!" − !!!!"          (5) 
 !!!!"!" = !!!!" + !!!!" − !!!!!" − !!!!"          (6) 
 !!!!"!" = !!!!" + !!!!" − !!!!!" − !!!!"          (7) 
 !!!!"!" = !!!!" + !!!!" − !!!!!" − !!!!"          (8) 
 !!!!"!" = !!!!" + !!!!" − !!!!!" − !!!!"          (9) 
 
 
Parameterization and Uncertainty Analysis 
 
Demographic and disease parameters were used to define the transitions into and out of 
compartments.  All parameters for the transmission-only model are defined in Table 4. 
(a) Demographic Parameters  
Census data were used to identify and calibrate point estimates for birth rate, child- and 
adult-specific death rates, and the rate of aging from child to adult compartments.  Calibration 
involved setting the birth rate equal to the estimate derived from census data and adjusting the 
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death and aging rates to achieve both empirical population-level growth rates and age 
structuring, respectively [29]. 
(b) Force of Infection Equation 
According to our model, the force of infection addresses two between-compartment 
relationships for the infectiousness of different groups of individuals.   
The first relationship involves the relative infectiousness of individuals in high versus 
low infection intensity compartments.  This relationship was quantified as a multiplicative factor 
relating β80 and β20 and was calculated as a ratio of the expectation of the lower 80 percent of the 
density function for population-level fecal egg counts and the expectation of the upper 20 percent 
of the same density function.  Egg counts were used as an indicator of infectiousness since 
excreted hookworm eggs contaminate soil in areas lacking developed sanitation systems and 
subsequently result in the development of infectious L3 hookworm larvae [6].  A binned 
negative binomial distribution and a flat prior were used to model the probability of a given egg 
count in eggs per gram (epg) of fecal sample.  Posterior distributions for mean and variance 
parameters of a negative binomial distribution were generated through the Markov chain Monte 
Carlo (MCMC) method.  Although the likelihoods of ! and !! estimates were considered in the 
MCMC, equations ! =    !! !! 1− ! !!  and ! =   ! !!, where !! = ! + !! !, were 
utilized to produce distributions for the number of successes (R) and probability of success (P) 
parameters specific to the calculation of the negative binomial cumulative distribution function 
in Matlab.  A single MCMC was conducted for children and adults since independence of the 
study populations could not be assumed; however, separate ! and !! parameters of the negative 
binomial distribution were evaluated for each of the two age classes.  The likelihood function 
(Equation 10) for this analysis was based on population-level data that classified individuals into 
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four categories of hookworm infection intensity based on fecal egg counts [10]. The function 
depends on !! = ! ! − !(!), or an individual’s probability of being in a given fecal egg count 
category (range: z epg – y epg), as determined by the negative binomial cumulative distribution 
function; !!" and !!" represent the number of children and adults, respectively, from the study 
sample in the ith non-zero fecal egg count category. ℓ !! ,!!!, !!,!!! = !!" ∗ log  (!!")!!!! + !!" ∗ log  (!!")!!!!       (10)  
Best-fit estimates for the four parameters were considered as those that maximized the 
log likelihood equation in 200,150 iterations, with an expected burn-in period of 150 iterations. 
The negative binomial distributions generated by the best-fit parameters resulting from this 
MCMC were used to determine the expected egg count of an individual in the lower 80% of the 
density function and the expected egg count of an individual in the upper 20% of the density 
function, and a ratio was taken.  To address the uncertainty in the estimates, the entire parameter 
distributions from the MCMC were used to produce vectors of ratios to be applied as a prior 
distribution for the multiplicative factor relating βC80 and βC20 or that relating βA80 and βA20 in the 
uncertainty analysis.   
The second relationship within the force of infection equation considered the relative 
infectiousness of adults versus children.  Unlike parasite burden of other soil-transmitted 
helminth infections which peaks during adolescence and subsequently declines, the mean 
number of hookworms per person increases gradually until plateauing during adulthood [6]. 
However, considerable between-community heterogeneity has been observed in the relative 
infectiousness of adults versus children [25, 30].  In accord with the findings of Chan et al [25] 
for a comparable sub-Saharan African community, it was assumed for the present analysis that 
Zanzibari children are twice as infectious as adults due to less hygienic practices and a higher 
	   10 
basic reproductive rate of worms; however, other relationships were considered in the 
uncertainty analysis.   
(c) Disease Parameters 
 Point estimates for baseline prevalence of hookworm infection for children and adults in 
Zanzibar were extracted from the available literature (Table 1). Prevalence estimates were 
assumed to follow the binomial distribution and be independent of one another. The MCMC 
method was used to determine the values of βC80 and ρ that maximized a log likelihood function 
based on the experimental prevalence data (Equation 11).  The beta-binomial distribution was 
assumed for the prevalence estimates.  In the equation, !! represents the prevalence estimate for 
children derived from a cross-sectional study by Stoltzfus et al [31] on Pemba Island, Zanzibar 
prior to mass drug administration and !! represents a prevalence estimate for Zanzabari adults 
[32], while !!!   and !!!  represent the prevalence levels predicted with a given set of parameter 
estimates. ℓ !!!",! = !!!! ∗ log !!! + !! − !!!! ∗ log 1− !!!  
    +  !!!! ∗ log !!! + !! − !!!! ∗ log 1− !!!     (11)  
Uninformative flat prior distributions were assumed for the two disease parameters.  For the 
uncertainty analysis, iterative Gibbs sampling was used to draw from the posterior distributions 
for the multiplicative factors relating βC80 and βC20 or that relating βA80 and βA20 to parameterize 
the force of infection equation.  
(d) Age Class Multiplier 
 Significant inter-community heterogeneity in the relative infectiousness of adults and 
children has been documented by Chan et al [25, 30].  For the present paper, it was assumed that 
children in Zanzibar are more infectious due to behavioral factors.  However, to address the 
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possibility of other relationships, the age-class multiplier was added as an additional parameter in 
the MCMC and allowed to vary randomly to consider the possible scenarios of increased 
infectiousness among adults and equal infectiousness between adults and children; the trend of 
the resulting MCMC output was visually inspected for convergence. 
 (e) MCMC Convergence Diagnostic 
The MCMC process was repeated to generate a series of two chains for each parameter; a 
burn-in period of 150 iterations of overdispersed values was used.  Convergence of posterior 
distributions was tested using the Gelman-Rubin diagnostic [33, 34].  This diagnostic uses the 
potential scale reduction factor (!), involving the estimated variance of a given parameter based 
on both the within- and between-chain variances, to determine whether the parameter 
distributions generated through the MCMC process converge to a stationary distribution 
(Criterion: ! < 1.2).  ! was calculated and the plot reflecting change in Gelman and Rubin's 
shrink factor was evaluated for each parameter [33]. 
 
Morbidity Measures 
Using published data on hemoglobin levels for a sample of Zanzibari children 
categorized according to five fecal egg count bins [31], the proportions of the susceptible (0 eggs 
per gram feces) and infected (>0 eggs per gram feces) populations with anemia were calculated.  
For individuals within a given fecal egg count range, hemoglobin (Hb) measurements were 
assumed to follow a normal distribution.  Underlying levels of anemia due to nutritional status, 
malaria, and other factors were also assumed.  The proportion of individuals with anemia not 
attributable to hookworm infection was found as the density of the cumulative distribution 
function below 90 g/L Hb for uninfected individuals.  A point estimate for the proportion of 
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susceptible children with anemia was calculated using the mean and standard deviation for 
hemoglobin levels among individuals in the 0 eggs per gram feces category.  For each fecal egg 
count category (i) of infected individuals, the density of the normal cumulative distribution 
function (A) under 90 g/L was multiplied by the proportion of the population with egg counts in 
that range (z epg – y epg), as determined using the best-fit parameters of the negative binomial 
distribution (F) found in the first MCMC (Equation 12).   !"#$#"%&#'  !"#ℎ  !"#$%& =    !! 90 − !!(0) ∗ ! !! − !(!!)!!!!    (12) 
For both susceptible and infected individuals, the uncertainty in the empirical data was 
addressed by drawing 10,000 random numbers from a normal distribution with the published 
mean and standard deviation for each fecal egg count range and randomly selecting a new mean 
for the distribution of anemia. Additionally, Gibbs sampling was used to select mean and 
variance estimates generated in the first MCMC for parameterizing the negative binomial 
distribution in the uncertainty analysis. 
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RESULTS  
Data 
Data on prevalence of hookworm infection in adult and child populations from Zanzibar 
or representative areas of eastern Tanzania were extracted from the available literature.  Pre-
treatment estimates for prevalence of hookworm infection were found for children and adults 
(Table 2).  The number of individuals in the high intensity compartments was calculated as the 
20% of the population expected to harbor the majority of the hookworm burden [6, 23].  
 
MCMC Convergence 
 The Markov chain Monte Carlo (MCMC) method was used to generate posterior 
distributions for mean and variance parameters of negative binomial distributions describing 
fecal egg counts in child and adult populations.  The Gelman-Rubin diagnostic (!) was found to 
be between 1.0 and 1.04 upon comparing two chains of parameter values for each of the four 
parameters considered in the MCMC. A similar analysis of convergence was conducted to 
evaluate the chains of posterior distributions of the two disease transmission parameters (!!!" 
and !) generated through the second MCMC.  Figure 2 reflects the tendency toward stationary 
distributions for the disease parameters based on the evolution of Gelman and Rubin's shrink 
factor.   
 When the age-class multiplier was allowed to vary to explore other possible relationships 
in the relative infectiousness of adults versus children, no convergence for this parameter was 
observed.  As a result, the relationship was fixed with children being twice as infectious as adults 
(!!!" = !! ∗   !!!") for the remaining analyses. 
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Model Predictions Using Point Estimates 
Best-fit point estimates were determined as values maximizing the log likelihood 
functions for parameterizing the negative binomial distribution and subsequently the 
transmission model.  All parameter estimates are presented in Tables 3 and 4.  It was found that 
children in the model had, on average, 1303 hookworm eggs per gram feces and that, on average, 
adults had 1622 hookworm eggs per gram feces. Children prone to high intensity infections were 
found to be 4.9 times more infectious as children prone to low intensity infections in terms of 
their relative fecal egg counts.  Adults prone to high intensity infections were similarly found to 
be 4.7 times more infectious as adults prone to low intensity infections.  Using this information 
to parameterize the force of infection equation and run the transmission model, it was determined 
that moderate-to-severe anemia affected 6.2% of susceptible children. Among infected children, 
16.4% were found to have hemoglobin levels less than 90 g/L.  Accordingly, the model predicted 
the prevalence of hookworm-attributable anemia among children to be 10.2%. 
 
Model Predictions with Uncertainty 
The Markov chain Monte Carlo process was implemented twice to account for 
uncertainty in the data used.  The first MCMC considered the distributions of fecal egg counts 
for adults and children. A jump size of 250 (acceptance ratio: 0.5296) and a jump size of 0.32 
(acceptance ratio: 0.5834) were used for !!  and !!!, respectively.  A jump size of 445 
(acceptance ratio: 0.5122) and a jump size of 0.40 (acceptance ratio: 0.6334) were used for !! 
and !!!, respectively.  The resulting distributions of likely means and variances for the negative 
binomial distribution were used to find either the risk-class multiplier relating βC80 and βC20 or 
that relating βA80 and βA20 (Figures 3 and 4).  When taking uncertainty into account, it was found 
	   15 
that the relative infectiousness of children in the high intensity infection compartment compared 
to that of children in the low intensity infection compartment ranged between 3.4 and 7.2.  The 
infectiousness of the adults in the high intensity infection compartment was found to be between 
2.8 and 12.2 times that of adults in the low intensity infection compartment.  Ranges of 
parameter estimates from the uncertainty analysis are presented in Table 3.  The second MCMC 
used Gibbs sampling to evaluate the force of infection equation and prevalence data to 
parameterize the overall transmission model.  A jump size of 0.0025 (acceptance ratio: 0.2699) 
and a jump size of 0.0001 (acceptance ratio: 0.3115) were used for !!!" and !, respectively.  It 
was determined that underlying levels of anemia affect between 0% and 99.7% of the modeled 
child population (! = 14.2%).  Among the infected children compartments, it was found that 
between 0% and 93.1% had hemoglobin levels less than 90 g/L (! = 24.1%). Figures 5 and 6 
are histograms representing the frequencies of proportions for moderate-to-severe anemia in 
susceptible and infected child populations, respectively.  Accordingly, when accounting for 
uncertainty, the model predicted rates of childhood anemia attributable to hookworm infection is, 
on average, 9.9%. 
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DISCUSSION 
Results and Implications 
Chronic hookworm infection is a leading but preventable cause of anemia and other 
morbidity throughout communities that lack access to sufficient hygiene and sanitation 
resources.  Despite efforts at mass drug administration, the global prevalence of hookworm 
infection remains high and post-treatment rebounding suggests that current measures are not 
sustainable [16].  Mathematical modeling offers an effective tool for considering population-
level transmission dynamics and provides the framework for evaluating the impact of future 
interventions against hookworm infection.  The present model is unique in that it is the first 
population-level compartmental model for human hookworm infection and that it does not 
depend on a worm burden threshold for determining levels of morbidity.  Worm- and individual-
based models have considered a wide range (40-160 worms) as the threshold for morbidity and 
extrapolating worm burden from fecal egg counts is variable and often unreliable [35, 36].  
Using empirical distributional data for hemoglobin levels and well-established trends in parasite 
aggregation, we were able to determine the proportion of children with underlying anemia versus 
anemia attributable to hookworm infection both with and without model uncertainty. 
 
Limitations 
 The present findings are limited by assumptions about the population-level distribution of 
hookworm infection.  In particular, risk stratification in the current model depends on the “80-20 
Rule” which accounts for both parasite aggregation and the observed tendency of a small 
proportion of the population having increased susceptibility to higher intensity infections.  
Specifically, according to this rule, it is expected that 20% of the population in a given 
	   17 
community harbors over 80% of the total worm burden [23].   The degree of parasite aggregation 
that corresponded with the data used to generate negative binomial distributions in the present 
study was considered in an a posteriori analysis. Gibbs sampling was performed to randomly 
select a mean/variance pair for children or adults and parameterize a negative binomial 
distribution.  Using the resulting distributions, 3213 and 1077 observations were randomly 
generated to represent the worm burdens for samples comparable in size to the original 
experimental samples of children and adults, respectively [31, 32].  For the distribution 
representing each age class, all observations were sorted and normalized by their sum.  Upon 
sorting, the observation representing the cutoff between the lower 80% of observed egg counts 
and the upper 20% of observed egg counts was determined.  This process was repeated for 5000 
iterations.  The mean density above the 80% cutoff (the 2571st observation for children and the 
862nd observation for adults) was found to be 70.09% for children and 71.11% for adults.   
The current model uses the 80-20 cutoff as a way of subgrouping the population 
according to risk level, so the fact that the empirical distribution does not follow the 80-20 
expectation does not immediately impact the findings.  However, despite wide use of this rule for 
risk stratification, an empirically supported approach to categorizing by host susceptibility and 
parasite aggregation should be investigated and the impact of this particular cutoff on our 
transmission model should be considered in a sensitivity analysis. 
 
Future Directions 
The transmission model was expanded structurally to account for treatment and 
vaccination against hookworm infection (Figure 7).  The intervention parameters and variables 
are described in Table 6.  Before implementation of the full intervention model, it will be 
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important to consider how treatment and vaccination efficacy will be measured.  Efficacy 
measured as the transition from infected to susceptible is expected to be an overly conservative 
approach since reduction in infection intensity without complete cure is sufficient to reduce 
morbidity.  That is, anemia and other comorbidities are more prevalent among individuals with 
high intensity infections [6].  To capture this in the S-I compartmental framework, we will 
evaluate shifts in the negative binomial distribution—widely accepted to reflect parasite 
aggregation and individual-level susceptibility to hookworm infection [23].  It is expected that a 
compartmental model which stochastically models individual predisposition to infection, parasite 
aggregation in the host population, and parasite density dependence will sufficiently capture this 
distributional change at the population level without the computational requirements of an 
individual-based model.  Treatment and vaccine efficacies will be modeled as binomial 
probabilities of an individual hookworm’s death due to intervention.  This approach was used by 
Sabatelli et al in modeling the impact of anthelminthic treatment [5].  Reinfection studies are 
expected to provide insight into the distributional nature of levels of susceptibility and the 
sensitivity of the model to risk stratification, as individuals with high intensity infection are more 
likely to return to the same infection intensity status after treatment effects wane. 
 
Conclusion 
In summary, despite the limited availability of empirical data, an uncertainty analysis of 
our hookworm model provides insight into population-level transmission dynamics and allows 
for estimation of directly unmeasurable quantities such as relative infectiousness and parasite 
aggregation.  Underlying trends in infection were evaluated in terms of age-class and risk-class 
multipliers and rates of moderate-to-severe anemia among both susceptible and infected child 
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compartments were determined using distributional data on hemoglobin levels across fecal egg 
count categories instead of relying on a worm burden threshold.  In addition, the structural 
framework for a compartmental model accounting for treatment and prophylactic measures was 
provided and recommendations were offered for parameterization and interpretation. 
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FIGURES AND TABLES 
FIGURE 1: Model of Human Hookworm Transmission 
 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 2: Demonstration of Markov chain Monte Carlo (MCMC) Convergence 
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FIGURE 3: Histogram of Multiplier Relating !!!" and !!!"for Mean Egg Count of High 
Intensity Versus Low Intensity Infection Adults 
 
 
 
FIGURE 4: Histogram of Multiplier Relating !!!" and !!!"  for Mean Egg Count of High 
Intensity Versus Low Intensity Infection Children 
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FIGURE 5. Histogram for the Proportion of the Susceptible Child Population with Moderate-to-
Severe Anemia 
 
 
FIGURE 6. Histogram for the Proportion of the Infected Child Population with Moderate-to-
Severe Anemia 
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FIGURE 7.  Full Epidemiological Model with Treatment and Vaccination Parameters (without 
risk stratification) 
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TABLE 1. Human Hookworm Vaccine Targets 
Target Vaccine Mechanism Stage in Vaccine Development 
Necator americanus 
Ancyclostoma-secreted 
protein 2 (Na-ASP-2) 
Attenuate L3 larval migration to the 
gastrointestinal tract; generate antibodies to 
decrease risk of hookworm disease due to heavy 
infections [37] 
Phase I clinical trial suspended in 
2007 due to safety concerns 
regarding reports of allergic 
reactions [38] 
Glutathione S-transferase  
(Na-GST-1) 
Interfere with the digestive proteolytic cascade that 
is responsible for heme detoxification [4] 
Part 2 of a Phase I clinical trial 
currently underway among adults 
in Brazil [39] 
Necator americanus aspartic 
protease 
(Na-APR-1) 
Target macromolecules required by the mature 
parasite to metabolize erythrocytes; particularly, 
interfere with hemoglobin proteolysis [7] 
Phase 1 study of safety and 
immunogenicity scheduled to 
begin in Washington, DC in June 
2013 [40] 
 
TABLE 2: Pre-Treatment Prevalence of Hookworm Infection 
Compartment Symbol Measure Prevalence Estimate Reference 
     
Infected, Asymptomatic 
Children  
Ic Prevalence of Hookworm Infection 
among Children (epg > 0) 
72.5%  [31] 
Infected Adults Ia Prevalence of Hookworm Infection 
among Adults (epg > 0) 
92.8% [32] 
 
TABLE 3: Descriptions and Estimates for Parameterization of the Negative Binomial Distribution 
Model parameter definition Symbol Best Fit Point Estimate Range 
    
Mean fecal egg count for 
children (eggs per gram 
feces) 
!!  1303.3  
 
1044.6-1691.0 
 
Aggregation parameter for 
children 
!!  0.8485 0.5196-1.5175 
Mean fecal egg count for 
adults (eggs per gram feces) 
!!  1621.6 657.7229-2536.7 
Aggregation Parameter 
(Adults) 
!! 0.8921 0.3054-2.1821 
Egg count cutoff between 
risk stratification categories 
for children (eggs per gram 
feces) 
 2123  1694-2706 
Egg count cutoff between 
risk stratification categories 
for adults (eggs per gram 
feces) 
 2633 1071-4151 
Ratio of relative 
infectiousness between 
children prone to high versus 
low intensity infection  
!!  4.8842 3.4039-7.1777 
Ratio of relative 
infectiousness between 
adults prone to high versus 
low intensity infection 
!! 4.7157 2.8324-12.2289 
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TABLE 4: Descriptions and Estimates of Transmission Model Parameters 
Model parameter definition Symbol Point Estimate (Value or Proportion)/ Point 
Estimate 
(Rate in months, if applicable) 
Reference 
Demographic Parameters:    
Population size N 981,750 people 
 
[29] 
Total Number of Children (15 years and 
younger) 
Nc 434,886 people [29] 
Total Number of Adults (15 years and 
older) 
Na 546,864 people [29] 
Birth rate b 45.5 births per 1000 people annually / 0.00325 
per month; b80=0.8 b and b20=0.2 b 
[29] 
Death rate (children under 15) dc 10.7 per 1000 population per year / 0.00140 per 
month 
[29] 
Death rate (adults 15 and over) da 6.4 per 1000 population per year / 0.00127 per 
month 
[29] 
Aging rate α 6.1% of children per year / 0.00335 per month [29] 
Disease Parameters:    
Force of infection γ Equation 1 
Present 
paper 
Effective transmission rate in children 
(low intensity infection) βC80 0.0164 
Present 
paper 
Effective transmission rate in adults (low 
intensity infection) βA80 
!! ∗ βC80 = 0.0082 Present paper; [25] 
Effective transmission rate in children 
(high intensity infection) βC20 !! ∗ βC80 = 0.0801 Present paper 
Effective transmission rate in adults 
(high intensity infection) βA20 !! ∗ βA80 = 0.0387 Present paper; [25] 
Rate of recovery from infected state ρ 0.8338 x 10-3 Present paper 
 
TABLE 5: Time Series Prevalence Estimate Data for Hookworm Infection 
Source Population Year Prevalence Estimate N Reference 
     
Total Infected Children  1998 73.3% 182 [41] 
Total Infected Children 2004 45.6% 228 [21] 
Total Infected Adults 2005 32.3% 929 [42] 
Total Infected Children 2007 18.3% 367 [43] 
Total Infected Population 2009 32.2% 184 [20] 
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TABLE 6: Description of Parameters and Variables for Full Intervention Model 
Model parameter definition Symbol Estimate Predicted 
Distribution 
Estimation 
Method/ 
Reference 
Treatment Parameters:     
Chemotherapy treatment coverage ν Six coverage terms sampled 
through MCMC and based on 
different treatment campaigns 
n/a 
 
MCMC 
Treatment efficacy rate εT 15% (mebendazole) 
72% (albendazole) 
Beta [17] 
Treatment Variables:     
Vaccine efficacy rate in terms of 
reducing force of infection  
εV1 Varied – 25%, 50%, 75%, 100% Beta MCMC; 
[5] 
Vaccine efficacy rate in terms of 
reducing progression to clinical disease 
εV2 Varied – 25%, 50%, 75%, 100% Beta MCMC; 
[5] 
Vaccine waning rate ω Varied – 1, 2, 3.5, 5 years  Exponential MCMC; 
[44] 
Vaccination coverage pV Varied – 25%, 50%, 75%, 100% 
per month 
n/a MCMC 
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